Trastuzumab is a humanized monoclonal antibody that binds selectively to HER2 with high affinity. Trastuzumab has antitumor activity and can be used for the treatment of HER2-positive tumors. Trastuzumab induces cell cycle arrest, mediates cytotoxicity, and inhibits DNA damage repair.